NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Guangzhou KingCreate Biotechnology Co., Ltd.

Guangzhou KingCreate Biotechnology Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttp://www.kingcreate.com.cn/

Last Round

Series C

Aug 1, 2023

Total Funding Raised

$15.3M

Company Overview

Guangzhou KingCreate Biotechnology Co., Ltd. is a biotechnology company that develops precision medicine solutions, including genetic sequencers, diagnostic instruments, and genetic testing kits for clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsnext-generation sequencingNGSpathogen detectiontargeted NGStNGSgenetic testingbioinformaticsclinical diagnosticsprecision medicinemultiplex PCRdiagnostic reagentsinfectious disease testinghybrid captureclinical lab equipmentliquid biopsy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou KingCreate Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Guangzhou KingCreate Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Guangzhou KingCreate Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 1, 2023
Series BDec 25, 2020
Series AJul 1, 2019

Guangzhou KingCreate Biotechnology Co., Ltd. Investors

Notable investors and investment history

Guangzhou KingCreate Biotechnology Co., Ltd. investors
InvestorRounds
Legend CapitalSeries A, Series C, Series B
E Fund ManagementSeries B
Shiyu CapitalSeries A
Peakview CapitalSeries C
China Development Bank CapitalSeries A

Guangzhou KingCreate Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou KingCreate Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou KingCreate Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year FoundedN/A
Last FundingAug 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.